Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Instagram Outage Disrupts Thousands of U.S. Users 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
TYSONS, Va. and CARRICK ON SHANNON, Ireland, Sept. 28, 2017 -- Cora Systems, a leading global provider of enterprise portfolio, program and project management (EPPM) solutions, has been named a finalist in the 2017 Pharma Industry Awards. Cora has been honored with the finalist designation in the “Pharma Supplier of the Year” category. The category winner will be announced at a ceremony on October 5 at the Clayton Hotel, Burlington Road, Dublin.
The annual awards program is presented in association with Kuehne + Nagel’s Pharma and Healthcare Division.
“We are extremely honored to have been singled out as a finalist in this prestigious awards program,” said Philip Martin, Founder and Chief Executive Officer of Cora Systems. “Our professional services teams and our EPPM software solution, ProjectVision, have been instrumental in helping pharmaceutical companies of all sizes drive successful outcomes for their projects.”
ProjectVision, Cora’s customized EPPM solution, is an intuitive web-based tool that offers specific benefits to the pharmaceutical industry such as process compliance, risk management, and project cost savings through Lean Management programs. In addition to the software, Cora’s professional services teams provide mentoring to achieve solution ROI in six months, or less. Additionally, Cora’s flexible approach provides a customizable solution that fits seamlessly into existing methodologies and practices, eliminating costly and time consuming re-training.
About Cora Systems
Cora Systems provides EPPM solutions and services to government agencies and large-scale global organizations, including life sciences, healthcare, and engineering & construction. Every day, thousands of project managers across the world use the Cora platform to manage their portfolio of projects, totaling over $ 10 billion in value, across multiple locations, dozens of countries and thousands of users. Headquartered in Ireland and with regional offices in Washington, DC and London (UK), Cora’s client roster includes Allergan, Boston Scientific and Eli Lilly. For more information, visit: www.corasystems.com.
Media Contacts:
Richard Fitzpatrick, Marketing Manager
Cora Systems:
+353 71 962 2078;
[email protected]
Dawn Fontaine
Ripple Effect Communications
508-353-3777
[email protected]
